4D Molecular Therapeutics, Inc. (FDMT) Operating income 2019–2025
4D Molecular Therapeutics, Inc. (FDMT) annual operating income history from SEC filings — each fiscal year as reported.
-$159.5MFY2025 · since FY2019: -$50.8M → -$159.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$159.5M | +15.1% |
| FY2024 | -$187.8M | -66.4% |
| FY2023 | -$112.9M | -2.6% |
| FY2022 | -$110.0M | -54.3% |
| FY2021 | -$71.3M | -25.9% |
| FY2020 | -$56.7M | -11.6% |
| FY2019 | -$50.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice